Cyclodextrins and Their Pharmaceutical Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 20 January 2025 | Viewed by 1184
Special Issue Editors
Interests: cyclodextrins; solubilization; stabilization; prodrugs; soft drugs; ophtalmic drug delivery
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to our Special Issue on "Cyclodextrins and Their Pharmaceutical Applications". This Special Issue aims to compile cutting-edge research and comprehensive reviews that explore the multifaceted roles of cyclodextrins in modern medicine. We seek contributions that highlight recent advancements, address current challenges, and propose future directions for the application of cyclodextrins in pharmaceuticals. The potential of cyclodextrins in pharmaceuticals was first recognized several decades ago, and since then, their use has expanded exponentially. These compounds have proven to be invaluable in improving the pharmacokinetic profiles of numerous drugs, particularly those with poor water solubility. By forming inclusion complexes, cyclodextrins can protect labile drugs from degradation, control the release rate of active pharmaceutical ingredients, and reduce drug volatility and odor. Such modifications not only enhance therapeutic efficacy but also improve patient compliance and safety. Beyond traditional drug delivery, cyclodextrins have shown promise in advanced therapeutic applications, including gene delivery, targeted cancer therapy, and the treatment of neurodegenerative diseases. Their biocompatibility and relatively low toxicity make them suitable for a wide range of biomedical applications. Furthermore, recent advancements in the chemical modification of cyclodextrins have opened new avenues for creating more specific and efficient drug delivery systems. The importance of cyclodextrin research lies in its potential to revolutionize the pharmaceutical industry. With ongoing innovations in synthesis, functionalization, and application, cyclodextrins continue to offer novel solutions for drug delivery challenges. Current research focuses on understanding the interactions at the molecular level, optimizing cyclodextrin-based formulations, and exploring new therapeutic targets.
This Special Issue aims to present a collection of innovative research and in-depth reviews that explore the various applications of cyclodextrins in the realm of modern pharmaceutical science. We are looking for submissions that demonstrate cutting-edge developments, tackle pressing issues, and provide forward-looking insights into the potential uses of cyclodextrins in drug development and delivery, including the following:
- Innovative methods for the synthesis and characterization of cyclodextrin complexes;
- The role of cyclodextrins in improving drug solubility and stability;
- Applications of cyclodextrins in targeted drug delivery systems;
- Clinical and preclinical studies demonstrating the efficacy of cyclodextrin-based formulations;
- Safety and toxicological evaluations of cyclodextrins in pharmaceutical applications, including regulatory status;
- Novel cyclodextrin derivatives;
- Cyclodextrins as APIs.
We look forward to receiving your contributions.
Prof. Dr. Thorsteinn Loftsson
Dr. Renata Maria Văruț
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cyclodextrin complexes
- drug delivery systems
- pharmaceutical applications
- solubility enhancement
- therapeutic efficacy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
